| Jordan Metcalf, DPT | |
|
1 Kendall Sq Ste B14104, Cambridge, MA 02139 | |
| (617) 491-0264 | |
| (617) 491-4411 |
| Full Name | Jordan Metcalf |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 1 Kendall Sq Ste B14104, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104311208 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bay State Physical Therapy Of Randolph Inc | 6305744251 | 307 |
News Archive
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
Cancer cells producing toxins that destroy tumours - could this be a future treatment for cancer? Researchers at Lund University have achieved good results in tests on both cells and animals.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
Illumina, Inc. today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing, including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.
In his latest Kaiser Health News column, James Capretta explores perspectives related to cost control in health reform.
› Verified 1 days ago
| Provider Name | Bay State Physical Therapy Of Randolph Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164474334 PECOS PAC ID: 6305744251 Enrollment ID: O20191112001187 |
News Archive
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
Cancer cells producing toxins that destroy tumours - could this be a future treatment for cancer? Researchers at Lund University have achieved good results in tests on both cells and animals.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
Illumina, Inc. today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing, including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.
In his latest Kaiser Health News column, James Capretta explores perspectives related to cost control in health reform.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Metcalf, DPT 790 Remington Blvd, Bolingbrook, IL 60440-4909 Ph: () - | Jordan Metcalf, DPT 1 Kendall Sq Ste B14104, Cambridge, MA 02139 Ph: (617) 491-0264 |
News Archive
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
Cancer cells producing toxins that destroy tumours - could this be a future treatment for cancer? Researchers at Lund University have achieved good results in tests on both cells and animals.
Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.
Illumina, Inc. today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing, including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.
In his latest Kaiser Health News column, James Capretta explores perspectives related to cost control in health reform.
› Verified 1 days ago
Sita Anajis Agterberg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Ms. Melissa Gayle Buffer, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 763 Massachusetts Ave Ste 7, Cambridge, MA 02139 Phone: 503-678-9806 | |
Miranda Mara Boucher, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Jessica Qiu, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1575 Cambridge St, Cambridge, MA 02138 Phone: 617-876-4344 | |
Sarah Martyn, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2422 | |
Daniel Woodward, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 256-426-4297 | |
Dr. Bridget Moran O'halloran, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 356 Third St, Cambridge, MA 02142 Phone: 617-536-1161 |